AI Verdict
MTVA has stronger fundamentals based on our AI analysis.
MTVA vs LTRN Fundamental Comparison
| Metric | MTVA | LTRN |
|---|---|---|
| Revenue | $510,000.0 | N/A |
| Net Income | $-13.0M | $-17.1M |
| Net Margin | -2,543.7% | N/A |
| ROE | -243.3% | -262.0% |
| ROA | -116.6% | -155.1% |
| Current Ratio | 1.93x | 2.40x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-7.35 | $-1.57 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MTVA vs LTRN: Frequently Asked Questions
Is MTVA or LTRN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MTVA has stronger fundamentals. MTVA is rated STRONG SELL (92% confidence) while LTRN is rated STRONG SELL (87% confidence). This is not investment advice.
How does MTVA compare to LTRN fundamentally?
MetaVia Inc. has ROE of -243.3% vs Lantern Pharma Inc.'s -262.0%. Net margins are -2,543.7% vs N/A respectively.
Which stock pays higher dividends, MTVA or LTRN?
MTVA has a dividend yield of N/A or no dividend while LTRN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MTVA or LTRN for long term?
For long-term investing, consider that MTVA has STRONG SELL rating with 92% confidence, while LTRN has STRONG SELL rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MTVA vs LTRN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MTVA vs LTRN, the AI consensus favors MTVA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.